...
首页> 外文期刊>BMC Surgery >Clinical analysis of treatment strategies to cholecystocholedocholithiasis patients with previous subtotal or total gastrectomy: a retrospective cohort study
【24h】

Clinical analysis of treatment strategies to cholecystocholedocholithiasis patients with previous subtotal or total gastrectomy: a retrospective cohort study

机译:回顾性队列研究回顾性研究了胆囊性胆总管结石病合并大肠切除或全胃切除的患者的治疗策略

获取原文
           

摘要

Previous gastrectomy can lead to an increased incidence of cholecystocholedocholithiasis (CCL) and increased morbidity rate. However, the appropriate treatment strategy for patients with CCL and a history of gastrectomy remains unclear. We performed a retrospective cohort study of patients with CCL and a history of gastrectomy who underwent either one-stage laparoscopic common bile duct (CBD) exploration with stone clearance and laparoscopic cholecystectomy (LCBDE+LC) or two-stage endoscopic retrograde cholangiopancreatography followed by LC (ERCP+LC) from May 2010 to March 2018. The success rate of ERCP for CBD stone clearance was 81.2% in patients with a history of Billroth I gastrectomy and 23.7% in patients with a history of Billroth II or Roux-en-Y esophagojejunostomy [χ2?=?97.67, P 3 points (χ2?=?59.70, P?
机译:先前的胃切除术可导致胆囊胆管结石症(CCL)的发生率增加和发病率增加。但是,对于CCL和有胃切除史的患者,适当的治疗策略仍不清楚。我们对CCL和有胃切除术史的患者进行了一项回顾性队列研究,这些患者均接受了一期腹腔镜胆总管(CBD)探查和结石清除和腹腔镜胆囊切除术(LCBDE + LC)或两阶段内镜逆行胰胆管造影术(ERCP + LC)从2010年5月至2018年3月。具有Billroth I胃切除术史的患者,ERCP清除CBD结石的成功率为81.2%,具有Billroth II或Roux-en-Y史的患者为23.7%食管空肠造口术[χ2?=?97.67,P 3分(χ2?=?59.70,P?<?0.001,RR?=?3.38和χ2?=?53.41,P?<?0.001,RR?=?3.27) 。根据这项研究的结果,ERCP + LC似乎是具有Billroth I胃切除术史的患者治疗CCL的有吸引力的策略,而LCBDE + LC似乎适合具有Billroth II或Roux- en-Y食管空肠造口术。术前评估腹腔内粘连有助于降低腹腔镜手术的转化率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号